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Abstract 
The use of Left Ventricular Assistive Devices (LVADs) is increasing for people with heart failure. The present computational fluid dynamics 
study provides insight into the significance of the flow ratio between the cannula and the aortic root on the prediction of lesion localisation in a 
typical LVAD configuration, which in turn affects the design and manufacture of these devices. Three cases were studied with varying 
percentages of flow through the two inlets; the cannula inlet was assumed steady-state, whilst the aortic root inlet had a scaled pulsatile profile, 
representative of the extent of heart failure. Results suggest that as the flow exiting the heart decreases in velocity, if not orientated properly, the 
jet exiting the cannula graft can ‘obstruct’ flow to the innominate, common carotid and left subclavian arteries. Therefore, patients with less 
severe heart failure will generally experience relatively good perfusion of these arteries. However, for the more severe cases of heart failure, the 
orientation of the cannula graft should be such that adequate perfusion to the aforementioned arteries is maintained.  
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1. Introduction 
Cardiovascular disease causes  over 4 million (47%) of 
all deaths in Europe each year [1]. Ventricular assist devices 
are an established form of treatment for patients with heart 
failure and result in clear survival benefit [2–6]. The 
INTERMACS report showed that, in 2011, roughly 1,800 
patients were implanted with LVADs (95% of which were 
continuous flow pumps), this number is expected to increase 
over time [7]. 
A complication post-operative of LVADs is the 
occurrence of thromboembolic events [8]. Pump thrombosis 
within the LVAD is not the only origin of emboli, 
mobilisation of atherosclerotic plaque within the ascending 
aorta, common carotid and subclavian arteries may also 
contribute due to high Wall Shear Stress (WSS) [9]. The 
occurrence and mobilisation of lesions within the ascending 
aorta is affected by the nature of the outflow cannula 
placement and function. Therefore, not only is it important 
to consider unfavourable haemodynamics within the LVAD, 
but also within the aorta, cannulas, common carotid, 
innominate and subclavian arteries.  
During the implantation of an LVAD, the inflow cannula 
connects the left ventricle to the LVAD, while the outflow 
cannula is anastomosed to the right anterior of the ascending 
aorta. Despite having significant effects on haemodynamics, 
design and placement of cannulas during both LVAD and 
Cardio-Pulmonary Bypass (CPB) often varies from surgeon 
to surgeon. The parameters to consider during cannula 
placement include: 
• Cannula tip design: has been shown to have an influence 
on thrombus formation and mobilisation [10–12]. 
Altering the end-hole tip design of a diffuser plays a 
significant role in head-neck perfusion when compared 
with altering the orientation during CPB [10]. There 
have been proposed cannula tip designs to improve 
aortic cannula practice such as a novel four-lobe swirl 
inducer [10,13]. A diffuser tipped cannula reduces flow 
velocities and WSS, therefore reducing the risk of 
mobilising atherosclerotic or thrombotic plaque [10]. A 
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group at RWTH Aachen University in Germany have 
developed a validated Computational Fluid Dynamic 
(CFD) model to analyse the effect of outflow cannula 
shape, with the intention of reducing the jet effect and 
increasing cerebral perfusion during CPB [11,14]. Their 
work suggests that work needs to be done to determine a 
velocity threshold associated with plaque mobilisation. 
• Cannula insertion angle and location: are both also 
crucial to reducing thrombus formation and mobilisation 
[10–12] and have been relatively widely studied [15–17].  
Insertion angle has a significant effect significant effect 
on WSS [18] and flow patterns and often leads to 
thrombosis and emergency surgery for device 
replacement [19,20]. It is widely accepted that large 
variations in flow velocities within the ascending aorta 
are dependent on the angle of the outflow cannula 
anastomosis relative to the ascending aorta [21,22]. The 
normal rule is to insert the cannula high up in the 
ascending aorta, however, it has been shown that 
positioning the cannula sufficiently far away from the 
brachiocephalic artery branch may be crucial in reducing 
backflow [10]. With the exception of [23], there is still 
some uncertainty as to whether inflow cannula (into the 
apex of the left ventricle) positioning contributes to the 
development of thrombosis or not [19], however, this 
work is more concerned with the impact of 
haemodynamics within the aorta and it’s neighbouring 
branches, therefore, the inlet cannula configuration will 
not be discussed any further in this work.  
• Pulsatile/continuous flow from LVAD/CPM machine: 
numerical work comparing the difference between 
pulsatile and continuous flow during CPB has shown 
that WSS is remarkably higher during pulsatile flow, 
which may induce arteriosclerotic plaque embolism [9].  
Despite there currently being a wide range of research 
surrounding cannula implantation, to the authors’ 
knowledge, there appears to be no emphasis on the ratio of 
blood flowing from the aortic root and that from the cannula 
outlet on the numerical prediction of lesion deposition. This 
ratio is likely to be highly dependent on the state of HF of 
the patient. Despite left ventricular function no longer 
significantly contributing to aortic flow post LVAD 
placement [24], it is feasible that the ratio between the flow 
entering the aorta via the LVAD and the native left ventricle 
has an impact on potential future cardiovascular 
complications. Therefore, there is scope for work that 
defines whether or not such a ratio has a significant 
relationship to the probability of the patient developing 
cardiovascular complications post LVAD implantation. If 
such a relationship is found to be important, it may 
influence the surgeon’s decisions during LVAD 
implantation or CPB surgery. 
Therefore, the aim of this work is to quantify the impact 
associated with prescribing different inlet flow ratios to the 
aortic root and cannula in an LVAD configuration on the 
CFD simulation of haemodynamics within the 
cardiovascular system for predicting the localisation of 
lesion. It is worth noting that any implications that arise 
from this study are also applicable to CPB. 
2. Method 
2.1. Geometrical model 
A review by [25] reveals that out of over 5000 patients 
with continuous-flow (second generation) LVADs, 77.7% 
were male. For this reason, a patient-specific model of a 23 
year old male with normal aortic function was used in this 
work. The aorta geometry was produced using SimVascular 
software (Simtk.org) to process Gadolimium-enhanced 
MRA image data (Open Source Medical Software Corp). 
The aorta geometry was then combined with a simplified 
cannula (10mm diameter) geometry of a continuous-flow 
LVAD (see Figure 1). An arbitrary cannula insertion angle 
of §20 degrees was used. The angle is relative to a surface 
that crosses through the centre of the anastomosis region 
and remains tangential to the ascending aorta wall. The 
cannula geometry was based on a typical continuous-flow 
LVAD configuration. This basis was chosen because the 
most common and successful second generation pump 
worldwide as bridge to transplant and destination therapy is 
the HeartMate II (Thoratec Corp, Pleasanton, CA, USA), 
which is a continuous-flow device [26]. The present 
geometry is representative of the typical configuration of a 
second generation pump, in which a 10mm diameter 
cannula is connected to the apex of the left ventricle, with 
the outflow graft anastomosed to the ascending aorta [26], at 
an angle such that the flow is directed through the aorta with 
even flow distribution.  
Figure 1. Schematic of the present configuration: an aorta (that of a 23 year 
old male) with normal aortic function with an LVAD outflow graft 
connected to the ascending aorta. (a) inlet/aortic root; (b) inlet/cannula 
graft; (c) outlets/right subclavian artery; (d) outlet/right common carotid 
artery; (e) outlet/left common carotid artery; (f) outlet/left subclavian 
artery; (g) outlet/thoracic aorta. 
2.2. Computational domain 
The geometry was meshed using ICEM-CFD version 
15.0. The mesh, which consisted of §4.3 million elements 
was based on a finite volume hybrid mesh consisting of 
tetrahedral elements within the core region and prism layers 
(3 elements thick) near the wall to allow for large spatial 
velocity gradients. In order to ensure the accuracy of the 
simulations, a series of steady-state computations with 
different mesh refinement were conducted to ensure grid 
independency prior to running the present computations. 
The computational domain with §3.8 million tetrahedron 
and §500,000 prism elements were considered to be 
sufficient here, as further mesh refinement could only result 
in less than 1% change in velocity and WSS at some 
examined sections.  
(a) 
(b) (c) 
(d) 
(e) 
(f) 
(g) 
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2.3. Boundary conditions 
In the present work, three cases are studied based on 
different combinations of inlets, as shown in Table 1. The 
flow ratios defined in the simulations represent the extent of 
heart failure of the patient.  
Table 1. Summary of cases studied in the present work. Constant cannula 
flow rates were obtained by time-averaging the healthy pulsatile flow rate 
and scaling accordingly. 
 Flow based on healthy heart flow rate 
 Aortic root (pulsatile) Cannula (constant) 
Test 1 40% 1.60 cm/s, 60% 
Test 2 50% 1.34 cm/s, 50% 
Test 3 60% 1.07 cm/s, 40% 
 
Steady, uniform mass influx’ were imposed over the 
entire cannula inlet boundary. Due to the pulsatile nature of 
the heart, a flat, pulsatile velocity waveform based on 
experimental data by [27] was applied at the aortic root and 
scaled to 40, 50 and 60% of the normal magnitudes reach by 
a healthy heart to simulate various extent of HF. The 
assumption of a flat velocity profile at the aortic inlet has 
been verified by various in vivo measurements using 
different animal models, which have demonstrated that the 
velocity profile distal to the aortic valve is essentially flat in 
the ascending aorta and only consisted of a weak helical 
component.[27].  
 
 Ŷ Standard   Ŷ Test 1 (40%)   Ŷ Test 2 (50%)   Ŷ Test 3 (60%) 
Figure 2. Inlet velocity pulsatile waveforms forms applied at the aortic 
root. Waveforms have been scaled based on the standard (grey curve) 
profile taken from experimental data by [27]. 
Similar to the works of numerous researchers including 
[27–30], a ‘traction free’ or ‘zero pressure’ Boundary 
Condition (BC) was applied to each outlet. No-slip BC is 
applied to all walls and a rigid wall model is also assumed, 
which has been shown to be a valid assumption [31].  
2.4. Numerical procedure 
Blood flow was defined as a three-dimensional, 
incompressible, isothermal, and laminar flow, whose 
governing equations are:  
 
Continuity equation,    
      
0=⋅∇ u (1)
 
Navier-Stokes equation,  
 
( ) uuuu 2pȡ
t
ȡ ∇+−∇=∇⋅+
∂
∂ η  (2)
 
where u is the velocity vector, t is the time, p is the 
pressure, and  is the dynamic viscosity of blood set to 
4.043 g/ms. The density (ȡ) of blood is assumed to be 1044 
kg/m3. Non-Newtonian fluid properties of the blood were 
neglected.  
The governing equations are solved numerically by a 
finite volume method and the CFD code, ANSYS-CFX 
(Version 15.0), using a fully implicit second-order backward 
Euler differencing scheme. Each simulation ran for one 
period (T) of 0.8s, with a time-step size of 0.032s. The 
convergence criterion (a normalised residual, obtained based 
on the imbalance in the linearised system of discrete 
equations) is set to 10-5 in this study. Commercial 
visualisation tool, Ensight (CEI Inc., Research Triangle 
Park, NC, USA) was used to post-process the results. 
3. Results and Discussion 
3.1. Haemodynamic parameters 
The localisation of various lesions including 
atherosclerosis, intimal hyperplasia and intimal thickening 
have been extensively studied and are related to different 
local haemodynamic metrics [32–34]. These haemodynamic 
parameters can be directly derived from the flow velocity 
fields obtained by CFD-based simulation tools. Whilst the 
performance of these parameters on predicting the 
localisation of atheroma is important in this study, the focus 
is on the sensitivity of these parameters to the BCs 
prescribed during the numerical simulation. 
The parameters chosen for the present analyses include 
WSS, Time-Averaged WSS (TAWSS) [35], TAWSS 
Gradient (TAWSSG) [36], Oscillatory Shear Index (OSI) 
[35], and Relative Residence Time (RRT) [37], calculated 
according to Eqs. (3)-(6), below. These parameters have 
been chosen because i) localised distribution of low-WSS 
and high-OSI strongly correlate with the locations of 
atheroma [35], ii) large spatial TAWSSG contributes to 
elevated wall permeability and atherosclerotic lesions [38], 
iii) platelet activation may be induced by the combination of 
large exposure time and highs shear stress [39–42], iv) 
stagnant and recirculating flow regions can cause platelet 
aggregation and thrombogenesis. 
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τ
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Figure 3 shows the distribution of the above metrics for 
all three tests and in what follows, each hemodynamic 
metric will be discussed separately: 
Test 1 Test 2 Test 3  
  
  
  
  
  
  
  
  
   TAWSS (Pa) 
0.42
 
0.34
0.26
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0.10
  
 
 
 
 
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       25
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Figure 3. Distributions of different haemodynamic parameters calculated for the aortic arch and descending thoracic aorta, viewed from outside the vessel. 
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TAWSS: overall, TAWSS values increased when 
progressing from Test 1 to Test 3, with Tests 2 and 3 
experiencing increases of 21% and 44%, respectively when 
compared to Test 1. With the exception of TAWSS 
decreasing by 5% and 9% within the cannula graft in Tests 2 
and 3, respectively, this is likely caused by the reduced 
imposed graft inlet velocity.  
TAWSSG: values again, progressively increased from 
Test 1-3, Test 2 (+33%), Test 3 (+71%). Peak magnitudes 
occurred within the ascending aorta and ascending branches. 
OSI: distribution remained relatively unaffected by the 
imposed flow ratios, with values of +2% and +3% for Tests 
2 and 3, respectively, in comparison with Test 1. However, 
OSI progressively increased within the cannula graft, this is 
most likely due to the increasing magnitude of the pulsatile 
flow flowing from the aortic root having more influence on 
the haemodynamics within the cannula graft as the velocity 
imposed within the cannula decreases. 
RRT: overall, values decrease within the aorta and 
ascending branches as tests progress (-13% and -20% for 
Test 1 and Test 2, respectively). The opposite, however, 
occurs with the cannula graft (+23% and +56% in Test 1 
and 2, respectively), this pattern is due to the flow ratios 
switching over, where the dominant flow effects change 
from being caused by the cannula to the aortic root flow.   
 
 (a)
 (b) 
Area Weighted Average 
TAWSS (Pa)
Area Weighted Average 
TAWSSG (Pa/m)
Area Weighted Average 
OSI (-)
Area Weighted Average 
RRT (1/Pa)
Ŷ Test 1   Ŷ Test 2   ŶTest 3
Figure 4. (a) Areas (A) on which area weighted average values are 
calculated. (b) Charts of area weighted average values of the metrics 
studied. Specific values for each area are shown in Appendix A. 
For more quantitative comparison, Figure 4 shows area-
weighted average values of TAWSS, TAWSSG, OSI and 
RRT evaluated over various locations within the aortic 
model.  
Time-averaged Velocity (TAV) distributions are shown 
on a monitoring plane within the aortic arch in Figure 5(b). 
A three-colour contour of TAV is also shown on the same 
monitoring plane (Figure 5c). Blue and red areas represent 
WSS<75% and WSS>125% of the average value evaluated 
over the shown area, respectively. Average values of Tests 
1-3 are 2.39, 2.81 and 3.23 cm/s, respectively. This figure 
suggests that with severe HF (40% of normal function) the 
high velocity jet from the cannula focuses most of the flow 
onto the wall directly opposite the cannula anastomosis 
location. Whilst as the function of the heart increases, the 
flow from the heart more evenly distributes the flow through 
the aortic arch.  
 
 
Test 1 Test 2 Test 3 
 
 
 
TA
V
: 4.6 
 1.8 (c
m
/s)
 

40% 50% 60% 
Percentage of flow from aortic root 
Figure 5. (a) Monitoring place within the aortic arch. (b) Distributions of 
TAV shown on the monitoring plane. (c) Three-colour contour of TAV 
shown on the monitoring plane within the aortic arch. Blue and red areas 
represent TAV<75% and TAV>125% of the average value evaluated over 
the shown area respectively. Average values of Test 1, Test 2 and Test 3 
are 2.39, 2.81 and 3.23 cm/s respectively.  
 
(c) 
(b) 
(a) 
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3.2. Limitations of this study 
Non-Newtonian fluid properties and fluid-structure 
interaction were neglected in this study with the intention of 
explicitly analysing the effects due to the flow split ratio 
between the cannula and aortic root boundary. However, 
there are a number of other limitations to this study that will 
have an effect on explicitly analysing the effects of the flow 
split ratios,  hence, the following limitations offer potential 
further work: 
• The section of geometry consisting of the cannula graft 
and anastomosis was a simplified model of the normal 
location, orientation, angle, diameter and curvature. 
Hence, if MRI obtained geometry of a patient with an 
implanted LVAD would have been used, the 
haemodynamics would be more physiologically accurate. 
• The results were not validated against in vivo data, 
however, this study aimed to draw attention to this area 
of research and assess its potential rather than an in-depth 
and validated analysis. 
• Each simulation was ran for one pulse period, ideally, the 
simulation will run for at least 3 periods, and results are 
recorded during the final period, this is to allow any start-
up effects to be negated. 
• To reduce solution time, the time increment in this study 
was relatively large, reducing the increment size would 
produce more accurate and stable results. However, the 
time increment size was found to be fair as it produced 
realistic results and this work is intended as a preliminary 
study to investigate this area’s worthiness of further 
study. 
• As alluded to earlier, research concerning the 
implantation of LVAD outflow cannula is also applicable 
to CPB to some degree, and vice versa. However, it is 
worth noting that the velocity from the cannula returning 
blood during CPB is often significantly higher than 
LVADs, thus increasing the risk of dislodging parts of 
atherosclerotic lesions, creating an emboli, which can 
ultimately result in stroke [10]. The results in this study 
are not representative of such a high jet velocity as it is 
focused on the flow from an LVAD. 
4. Conclusion 
These results suggest that patients with less severe extent 
of HF will generally experience good perfusion of 
innominate, common carotid and left subclavian arteries, 
however, for the more severe cases of HF, the orientation of 
the graft anastomosis should be such to maintain adequate 
perfusion to these arteries, as the flow exiting the heart 
decreases, if not orientated properly, the jet of the cannula 
graft can ‘obstruct’ flow to the aforementioned arteries. 
This work does however require more extensive 
investigation to more reliably define the effects flow ratios 
between the cannula jet and the heart output have on the 
deposition of CVDs, particularly; results require validation 
against in vivo data; finer time step sizes and a greater 
number of time periods. 
This work is a good preliminary study for further 
investigation into the optimal combination of cannula tip 
design and cannula location relative to the condition of the 
patient. The data from such a study could prove useful for 
pre-operative planning, whether the patient has total or 
partial HF, the data will be able to direct the surgeon to an 
optimal surgical strategy in order to reduce post-operative 
risk of CVDs. 
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Appendix A. Area weighted average values of metrics 
studied 
Table 2. Area weighted average values of TAWSS, TAWSSG, OSI and 
RRT evaluated over various locations shown in Figure 4. 
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